Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors

Atalar, Banu; Mustafayev, TZ; Sio, TT; Sahin, B; Gungor, GORKEM; Aydın, GOKHAN; Yapici, BULENT; Ozyar, Enis

doi:10.2478/raon-2020-0039

Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors

Atıf İçin Kopyala

Atalar B. , Mustafayev T., Sio T., Sahin B., Gungor G. , Aydın G. , ...Daha Fazla

Radiology and Oncology, 2020 (SCI İndekslerine Giren Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası:
Basım Tarihi: 2020
Doi Numarası: 10.2478/raon-2020-0039
Dergi Adı: Radiology and Oncology

Özet

Background. Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and oligometastatic tumors.